Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Gamma-hydroxybutyrate associated with dependence liability

March 4, 1997

Sustained-release methylphenidate for HIV-associated cognitive impairment

March 4, 1997

Gliatech receives grant for histamine H3 receptor antagonists

March 3, 1997

Novel polyamines fromTeva

March 3, 1997

NeoTherapeutics seeks approval for trials on neurological drug

Feb. 28, 1997

MS&D describes nonpeptide tachykinin antagonists

Feb. 28, 1997

Sigma-receptor antagonists disclosed by Taisho

Feb. 28, 1997

Taiho discloses anxiolytics

Feb. 28, 1997

Riluzole now available in France

Feb. 27, 1997

Glaxo Wellcome evaluates ondansetron alone and in combination for emesis

Feb. 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Medtronic bolsters pain portfolio in $650M SPR Therapeutics buy
BioWorld
Medtronic plc is strengthening its pain management portfolio with its $650 million move to buy SPR Therapeutics Inc. and bring the company’s peripheral nerve...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...